Historical record - last NADAC effective date: 1/15/2019
Product Information
LOTREL 10-20 MG CAPSULE is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $11.2952 per EA under NDC 00078036405. Its NADAC has been published 321 times since Nov 28, 2013.
FDA first approved this application on Mar 3, 1995.
The High Outlier badge above means this manufacturer's average price in the amlodipine besylate and benazepril hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10; 20 mg/1; mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078036405
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
1/15/2019
Active Ingredients
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020364FDA Approved
3/3/1995
On Market Since
3/3/1995
Pharmacological Classes
Price Statistics
The NADAC for LOTREL 10-20 MG CAPSULE has been published 321 times since Nov 28, 2013, and over the history we have for it it has risen 110.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.2952 per EA |
|---|---|
| All-time high | $11.2952 (Jan 15, 2020) |
| All-time low | $5.3646 (Nov 28, 2013) |
| Median price | $9.3113 |
| Average price | $9.0785 |
| Largest weekly change | +14.9% (Jan 14, 2015) |
| Weeks tracked | 321 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+110.6%
Last surveyed Jan 15, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the amlodipine besylate and benazepril hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Novartis Pharmaceuticals Corporation manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
amlodipine besylate and benazepril hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LOTREL 10-20 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LOTREL 10-20 MG CAPSULE, manufactured by Novartis Pharmaceuticals Corporation, is $11.2952 per EA (NDC 00078036405), effective Jan 15, 2020.
How has the price of LOTREL 10-20 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LOTREL 10-20 MG CAPSULE has risen 110.6%. It has been tracked across 321 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LOTREL 10-20 MG CAPSULE?
Since Nov 28, 2013, the NADAC for LOTREL 10-20 MG CAPSULE has ranged from a low of $5.3646 (Nov 28, 2013) to a high of $11.2952 (Jan 15, 2020), with a median of $9.3113 per EA.
Are there cheaper alternatives to LOTREL 10-20 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of LOTREL 10-20 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LOTREL 10-20 MG CAPSULE?
LOTREL 10-20 MG CAPSULE (NDC 00078036405) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.